Observational Study in Patients With Previously Unresectable Malignant Pleural Mesothelioma Treated With Nivolumab and Ipilimumab (MESO-IMMUNE)
Clinical trial NCT05308966 · COMPLETED
Trial details
- NCT number
- NCT05308966
- Sponsor
- Groupe Francais De Pneumo-Cancerologie
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2022-05-03
- Primary completion
- 2025-08-27
- Enrollment
- 204
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.